Abbott Laboratories
NYSE: ABT
$115.90
+$0.87 (+0.8%)
Closing Price on November 15, 2024
ABT Articles
24/7 Wall St. screened the Merrill Lynch health care universe and found four pharmaceutical stocks rated Buy with outstanding short-term and long-term potential.
Published:
Earnings season is hitting its stride next week, and the health care sector, the biotech stocks in particular, have been on a roll for the past 12 months.
Published:
Last Updated:
Generic drug maker Mylan has proposed to acquire rival Perrigo for $205 per share in cash and stock.
Published:
Last Updated:
Mylan has announced that it will have a 35 million share secondary offering. At Tuesday's closing price of $59.35, the offering would be valued at $2.08 billion.
Published:
Friday's top analyst upgrades, downgrades and initiations include Cameron International, Dollar General, Genworth Financial, Groupon, SunPower, Visa and Yahoo.
Published:
The following companies were featured in a new Leerink report on understand testing trends for sexually transmitted diseases.
Published:
Here are five stocks that Jefferies highlights in its research report that have catalysts that could be important this week.
Published:
The U.S. Treasury has finally made its proposed effort to deal with the waves of corporate tax inversions that have created such a stir of late.
Published:
Add one more to the litany of pharmaceutical company mergers that are being made to avoid U.S. taxes. Mylan's existing business with part of Abbott's generic drug business.
Published:
Last Updated:
The Department of Defense awarded $10.46 billion in defense contracts Tuesday. The winning defense contractors included included Olin Corp., Boeing, and General Dynamics. The non-defense related...
Published:
These are the top Wall Street analyst upgrades, downgrades and initiations seen on Monday, May 19, 2014. They include Altria, CenturyLink, Micron, GoGo and AT&T.
Published:
Shares of Target took a hit of around 3% Monday morning following the resignation/firing of CEO Gregg Steinhafel. The interim CEO and chairman do not seem like serious candidates for the job.
Published:
Last Updated:
ThinkstockThe intense analysis of quantitative managers may seem like drudgery, but it can turn up absolute gems for investors looking for solid long ideas. In fact, firms like RBC use as much as 18...
Published:
Baxter International is taking an activist investor role of its own. The health care company has announced that it is splitting itself into two separate companies.
Published:
The Jefferies "Franchise" stock picks for 2014 are an eclectic group that may offer investors some ideas that are not highly touted on Wall Street. If the Jefferies team is right, these top stocks to...
Published:
Last Updated: